Joel M Baumgartner

4PUBLICATIONS
22CO-AUTHORS
Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 16, 2024
Cyclin-Dependent Kinase 4/6 Inhibition as a Novel Therapy for Peritoneal Mucinous Carcinomatosis With GNAS Mutations.

Jonathan Weitz, Daisuke Nishizaki, Joy Liau

|Jul 12, 2023
Role of Circulating Tumor DNA Among Patients with Colorectal Peritoneal Metastases.

Joel M Baumgartner, Gregory P Botta

|Sep 06, 2022
An Ex Vivo Organotypic Culture Platform for Functional Interrogation of Human Appendiceal Cancer Reveals a Prominent and Heterogenous Immunological Landscape.

Jonathan Weitz, Tatiana Hurtado de Mendoza, Herve Tiriac

|Jan 07, 2022
Palbociclib as a Novel Therapy for Low-Grade Mucinous Carcinomatosis Peritonei of Appendiceal Origin.

Betzaira G Childers, Divya Sood, Rohini Patel

Pageof 1